Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117364) titled 'RANDOMIZED CONTROLLED TRIAL ON EFFICACY OF LOW DOSE THALIDOMIDE IN CNS TUBERCULOSIS' on Sept. 10.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Stratified block randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded
Primary Sponsor: Investigator Initiated Trial
Condition:
Health Condition 1: A178- Other tuberculosis of nervous system
Intervention:
Intervention1: RANDOMIZED ...